Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-537068
Filing Date
2016-04-11
Accepted
2016-04-11 15:44:02
Documents
4
Period of Report
2016-05-11
Effectiveness Date
2016-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A d138336ddef14a.htm DEF 14A 631792
2 GRAPHIC g138336g06p83.jpg GRAPHIC 26781
3 GRAPHIC g138336pc001.jpg GRAPHIC 130192
4 GRAPHIC g138336pc002.jpg GRAPHIC 147879
  Complete submission text file 0001193125-16-537068.txt   1053004
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-14656 | Film No.: 161565081
SIC: 2836 Biological Products, (No Diagnostic Substances)